Miroslav Peřina

3,5,7-Substituted Pyrazolo[4,3-<i>d</i>]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders

Radek Jorda, Libor Havlı́ček, Miroslav Peřina et al. · Journal of Medicinal Chemistry · 2022 · 33 citations · Full text

Modulation of FLT3-ITD and CDK9 in acute myeloid leukaemia cells by novel proteolysis targeting chimera (PROTAC)

Eva Řezníčková, Soňa Krajčovičová, Miroslav Peřina et al. · European Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +17

3,5,7-Substituted Pyrazolo[4,3-<i>d</i>]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models

Radek Jorda, Libor Havlı́ček, Antonín Šturc et al. · Journal of Medicinal Chemistry · 2019 · 27 citations · Full text

Synthesis of dihydrotestosterone derivatives modified in the A-ring with (hetero)arylidene, pyrazolo[1,5-a]pyrimidine and triazolo[1,5-a]pyrimidine moieties and their targeting of the androgen receptor in prostate cancer

Márton A. Kiss, Miroslav Peřina, Václav Bazgier et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2021 · 17 citations · Full text

3<i>H</i>-Pyrazolo[4,3-<i>f</i>]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo

Neetu Dayal, Eva Řezníčková, Delmis E. Hernandez et al. · Journal of Medicinal Chemistry · 2021 · 17 citations · Full text